C oncern about adjacent disc degeneration (ADD) following spinal fusion has contributed to the development and implementation of motion-preserving alternatives such as lumbar total disc replacement (TDR) in the surgical treatment of low back pain (LBP). 1, 2 According to the literature, ADD is mainly influenced by aging and genetics, 3 and may develop regardless of any surgery. 1, 4, 5 In a metaanalysis 6 of four randomized studies with a mean follow-up of 13 years after spinal fusion or nonoperative treatment, ADD was more strongly related to aging than to fusion, but was not associated with the clinical outcome. In the only randomized study of ADD after TDR versus nonoperative treatment, 7 ADD was neither related to TDR nor the clinical outcome at 2-year follow-up. The aim of the present study was to assess the long-term development of ADD after TDR or nonoperative treatment, and to analyze the association between ADD development and the clinical outcome.
MATERIALS AND METHODS
This is a randomized multicenter study with 8-year followup conducted at five university hospitals in Norway. 8 
From the
The 8-year follow-up was approved by the Norwegian Regional Ethical Committee South East C (2011/2177). The project was conducted in accordance with the Helsinki Declaration and the ICH-GCP guidelines and it was registered at www.clinicaltrial.gov under the identifier NCT01704677 before it commenced. Results are reported according to the CONSORT standard.
Patients
Inclusion criteria for the original randomized trial were age 25 to 55 years, LBP as the main symptom for at least 1 year, Oswestry Disability Index (ODI) score ! 30 and degenerative changes at the disc levels L4/L5 and/or L5/S1 on magnetic resonance imaging (MRI). For further details, see Hellum et al. 9 The present study included patients available for both radiological and clinical examination at 8-year follow-up. Patients who had been operated with lumbar fusion during follow-up were excluded.
Interventions

Nonoperative Treatment
The nonoperative treatment consisted of modern multidisciplinary rehabilitation with a cognitive approach and supervised physical exercise over 3 to 5 weeks, according to Brox et al.
10
TDR
In the TDR procedure, the degenerative intervertebral discs L4/L5 and/or L5/S1 were removed and replaced with artificial discs (ProDisc II, Synthes Spine, West Chester, PA), as detailed previously. 9 
Clinical Outcome
Pain and disability were evaluated with the Norwegian version 2.0 of the ODI 11, 12 (scores range from 0 to 100, with a lower score indicating less pain and disability). LBP was measured with a visual analogue scale (VAS) ranging from 0 (no pain) to 100 (worst pain imaginable). We also collected information on reoperations due to ADD.
MRI Evaluation
MRI variables for evaluating ADD were analyzed at the nearest level above the implanted or degenerated index level, that is, at L3/L4 or L4/L5. MRI performed before treatment and at 8-year follow-up included (a)sagittal T2-weighted fast spin echo (FSE) and/or DRIVE images (FSE with 908 flip-back pulse); (b) sagittal T1-weighted spin echo or fast fluid-attenuated inversion-recovery images; and (c) axial images of the lower lumbar levels (T2-, T1-or proton density-weighted). All follow-up MRIs and >90% of pretreatment MRIs were from 1.5 T units. Metal artefact reducing techniques 13 were used on 97% of follow-up MRIs and implied thin slices (3 mm) and increased pixel bandwidth (BW), echo train length (ETL), and number of excitations (NEX). These follow-up MRIs included (a) sagittal T2-weighted FSE images: repetition time (TR)/echo time Pre-treatment and follow-up images were anonymized, presented together in a random order and evaluated independently by two radiologists from different institutions who had more than 15 years of experience in spine imaging. The observers could not be blinded to treatment but were blinded to clinical data. They rated changes in MRI findings by comparing 8-year follow-up and pre-treatment images on a clinical picture archiving and communication system (PACS) unit.
Six ADD variables were rated: Extent of Modic changes, 14, 15 disc height, 16 disc contour, 17 disc herniation size, 17 nucleus pulposus signal, 18 and posterior high-intensity zone (HIZ) 19 (Table 1) . Conclusive ADD ratings were based on both the observers' independent ratings and consensus between them in every instance of disagreement (review and discussion of images and findings). The interobserver agreement on increased rating value (yes/no) from pre-treatment to follow-up was fair for disc contour (kappa 0.37, disagreement 21%, mean yes rate 21%) and mostly good for the five other ADD variables (kappa 0.60-0.76, disagreement 3-10%, mean yes rate of 27% for nucleus pulposus signal, and otherwise 7-12%). 20 
Statistical Analysis
The primary outcome measure was increased ADD (yes/no), defined as increased rating value from pre-treatment to follow-up for at least one ADD variable, as in a previous report. 7 Possible rating values are defined in Table 1 . Decreased ADD (yes/no) was defined as decreased rating value for at least one ADD variable. Unchanged ADD implied that all rating values were unchanged. Two patients who had an increased rating value for one ADD variable and a decreased rating value for a different ADD variable were both classified as having increased ADD.
For each ADD variable, we compared changes in ratings between the treatment groups. We performed crude comparisons using a x 2 test or a Fisher exact test for categorical variables and an independent two-sided t test for continuous variables. Patients who were randomized to TDR but not operated were analyzed in the nonoperative group, and patients randomized to rehabilitation who later received TDR were analyzed in the TDR group, according to astreated principles (Figure 1) .
In a sensitivity analysis, we compared the proportions of patients with overall increased ADD in each group after excluding patients randomized to rehabilitation who later received TDR.
In order to analyze possible associations between increased ADD and the clinical outcome adjusted for possible confounders, we fitted a multiple linear regression model. In this model, we excluded those who were not treated according to randomization, as the treatments influence the clinical outcome. The model included ODI change from baseline to follow-up as the dependent variable and the following independent variables: Developed/increased extent of Modic changes (yes/no), disc height reduction (yes/no), disc contour worsening (yes/no), decreased nucleus pulposus signal (yes/ no), developed HIZ (yes/no), age, gender, and type of treatment (nonoperative/TDR). Increased herniation size occurred in only one patient and was therefore not part of the regression model. The model fit was good, with normally distributed residuals. The results are presented as an estimate of beta with 95% confidence intervals (95% CIs). We also performed a multiple logistic regression with the same independent variables as above and ''a satisfactory symptom state'' (ODI 22 points at follow-up) (yes/no) 21 as the dependent variable. A significance level of 5% was used for all analyses. All analyses were considered exploratory so no correction for multiple testing was done. All statistical analyses were performed using SPSS version 24.0 (IBM SPSS Statistics for Windows, IBM Corp., Armonk, NY).
Post Hoc Analysis
Post hoc, we analyzed the severity of ADD development on the basis of the number of worsened ADD variables. We compared the proportions of patients from each treatment group with increased rating for none, one, two, three, four, five, and six ADD variables.
RESULTS
In the original TDR group, 77 of 86 patients received the TDR, 14 were not available for follow-up, four patients could not be analyzed as they were operated on with spinal fusion, and in one patient, the pre-treatment MRI was untraceable. Therefore, only 58 of the original TDR group could be included. In addition, we included 11 patients randomized to rehabilitation who crossed over and were treated with TDR (median time since surgery was 74 (range 61-85) months). Consequently, 69 patients treated with TDR were analyzed. In the original rehabilitation group, 14 of 87 patients had been treated with TDR and five with spinal fusion, 15 were not available for follow-up, and one Posterior highintensity zone (HIZ)
An area of high-signal intensity in the posterior annulus fibrosus, brighter than or equally as bright as cerebrospinal fluid on sagittal T2-weighted images, and surrounded superiorly, inferiorly, and anteriorly by the low-intensity signal of the annulus fibrosus.
patient had an untraceable pre-treatment MRI. Therefore, only 52 of the original rehabilitation group could be included in the analyses. In addition, we included five patients randomized to surgery who were not operated. Thus, 57 patients treated nonoperatively were analyzed (Figure 1 ). The two treatment groups had similar pre-treatment clinical, demographical, and radiological characteristics ( Table 2 ). The 126 patients included in the present analyses had similar pretreatment clinical, demographical, and radiological characteristics, and similar outcome measures at 8-year follow-up, as did the 47 patients who could not be included (P ! 0.12 for all analyzed variables, data not shown). At 8-year follow-up, 23 patients (40%) in the non-operative group and 29 patients (42%) in the TDR group had increased ADD (P ¼ 0.86). The increase was due to developed/increased extent of Modic changes, development of HIZ, decreased nucleus pulposus signal and/or disc height, worsened disc contour, and/or increased herniation size ( Figure 2 , Table 3 ). Three patients (5%) treated nonoperatively versus two patients (3%) treated with TDR had decreased ADD (P ¼ 0.66). Regression of ADD was due to disappearance of HIZ in three patients, disappearance of Modic changes in one patient, and regression of disc herniation in one patient. The change in rating from pre-treatment to 8-year follow-up did not differ significantly between the treatment groups for any of the ADD variables ( Table 3) .
The sensitivity analysis confirmed our results. After exclusion of the 11 patients randomized to rehabilitation and treated with TDR, 23 patients (40%) in the nonoperative group and 24 patients (41%) in the TDR group had increased ADD (P ¼ 0.89).
None of the patients who were originally treated nonoperatively had been operated at the adjacent level. One patient treated with TDR at L5/S1 had been reoperated 17 months after the initial procedure with fusion from L4 to S1, thus fusing the adjacent level.
In the multiple linear regression analysis of the association between increased ADD and the clinical outcome, the only variable that was significantly associated with change in ODI at follow-up was type of treatment (nonoperative or TDR) (B ¼ 7.2, 95% CI 0.5-13.8, P ¼ 0.04). Therefore, we analyzed each treatment group separately. However, we did not find any significant association between increased rating in any ADD variable and change in ODI (R 2 ¼ 0.06, P ¼ 0.85) in patients treated nonoperatively and (R 2 ¼ 0.10, P ¼ 0.50) in patients treated with TDR. Multiple logistic regression analysis did not reveal any association between the increase in any ADD variable and ODI 22 points.
Post Hoc Analysis
The two treatment groups did not differ significantly with regard to the proportion of patients with increased rating value for one, two, three, or four ADD variables (P ¼ 0.38) (Figure 3) . 
DISCUSSION
This 8-year follow-up of the first randomized trial to compare TDR with nonoperative treatment revealed no difference in ADD development between the treatment groups. This supports the theory that ADD development is part of the natural course of degeneration. Furthermore, the ADD development was not related to the clinical outcome.
In each treatment group, a larger proportion of patients had increased ADD at the 8-year follow-up than at the 2-year follow-up (40% vs. 19% after nonoperative treatment and 42% vs. 13% after TDR). 7 A further increase is expected with longer follow-up.
Reduced range of motion (ROM) in the prosthesis has previously been reported to be associated with an increased prevalence of ADD. 22 , 23 We did not measure ROM at 8-year follow-up, but at 2-year follow-up, 24 segmental ROM was similar for an average disc prosthesis as for a degenerated index level disc. This may have contributed to similar ADD development in both treatment groups. In a previous review of ADD following back surgery, Harrop et al. 25 found a large variation in the reported ADD (0-24% of the patients 3-17 years after TDR). However, the included studies were heterogeneous and had major limitations. The large variation in ADD most likely reflects differences in patient characteristics (e.g., age), follow-up time, and ADD assessment methods. Such methods were either not reported or included disc height, osteophyte formation, or instability on flexion-extension images. The variation in ADD assessment makes it difficult to compare the proportions of patients with ADD increase, also between recent studies. Zigler et al. 26 based ADD on disc height reduction, endplate sclerosis, osteophytes, and spondylolisthesis on radiographs. They found increased ADD in 9% of patients five years after TDR. We found a much higher proportion (42%) with increased ADD at 8-year follow-up. The difference may partly be due to our use of MRI to detect changes not visible on radiographs (Table 3) . Regardless of allocation, 91 patients in our cohort have been treated with TDR, 8 of whom one (1%) has been reoperated with fusion including the adjacent segment. This is in agreement with other studies reporting reoperation due to ADD in 0% to 1% of patients after 2 to 5 years following TDR. [27] [28] [29] We found no significant association between increased ADD and the clinical outcome at 8-year follow-up. This is in line with a previous report from Huang et al. 22 and with the results of a recent cross-sectional analysis of long-term follow-up data from four randomized trials comparing nonoperative treatment with fusion for chronic LBP. 6 The main strength of this study is its original randomized design that allows for prospective comparison of ADD development after TDR with the course of ADD in patients treated nonoperatively. Other strengths are the public financing of the study, the long follow-up time, the metal artefact reducing MRI protocol, the MRI evaluation performed independently by experienced radiologists blinded to the clinical outcome, and the direct comparison of postand pre-treatment MRIs to assess changes in ADD. Such comparison can reduce overrating of changes due to ambiguous findings or small differences in MRI techniques and can improve agreement on changes in ratings. 30 In this study, the agreement was mostly good, despite instances where a low prevalence of change tended to reduce many of the kappa values. The conclusive combined ratings from both observers were likely to be even more reliable, 31 reducing the chance of underestimating the MRI findings' relationship to other variables. 32 We studied a broad range of separate ADD variables. There are several ways to describe ADD, and no gold standard exists. The commonly used Pfirrmann system 33 provides a single rating of disc degeneration based on the Figure 2 . Increased degeneration of the adjacent disc from baseline to 8-year follow-up after nonoperative treatment (1-2) and total disc replacement (3) (4) . A ¼ Modic changes, B ¼ changed signal intensity of the disc, and C ¼ reduced disc height.
height, structure and signal of the disc, and the distinction of nucleus and annulus. This system does not separate disc signal from disc height, and it does not include disc contour/ herniation or HIZ -nor Modic changes, which were related to clinical outcome after TDR in our cohort in both the short- 34 and long-term. 35 Similarly, as at 2-year follow-up, 7 we accepted an increase in only one ADD variable as indicating increased ADD. We were thus able to detect even small increases and differences in ADD.
The main limitations of the present study are its small sample size and that only 73% of the original sample could be included. This may call the generalizability of the results into question.
A further limitation is the choice of an as-treated analysis as the main analysis, as not all patients were analyzed according to the original randomization. However, the analyzed treatment groups had similar pre-treatment clinical, demographical, and radiological characteristics. As 24% of the patients randomized to rehabilitation were treated surgically, and 10% of those randomized to TDR were not operated, 8 we considered an intention-to-treat analysis to be unsuitable for analyzing the influence of TDR on ADD.
The 11 patients who crossed over from rehabilitation to TDR had a shorter observation time. This may have reduced the proportion with increased ADD in the TDR group, but results were unchanged in the sensitivity analysis excluding these 11 patients. The radiologists could not be blinded to the treatment group, which represents a possible observer bias. They were not blinded to post-treatment images when assessing pretreatment images, and this may have influenced their pretreatment ratings. Disc prostheses leave metal artefacts on the images close to the implant, but, according to previous reports, [36] [37] [38] such metal artefacts barely affect the evaluation of the adjacent disc level, and the metal artefact reducing MRI protocol further reduced the extent of the artefacts (Figure 2 ). The artefacts might hide the caudal part of large Modic changes extending caudally from the upper adjacent level, but we could still assess change in the size of Modic changes in all patients in our study.
The choice of the primary outcome variable may be debated. Increased ADD (yes/no) was a mainly qualitative variable. Only one of the six underlying ADD variables (disc height) was based on an actual measurement. Our study still provides more information than studies restricted to disc height measurement alone. By defining increase in ADD as a dichotomized variable, we did not use information on the degree of the increase. It is not clear how a variable reflecting the overall degree of increase in ADD can be constructed and weighted based on increases in different underlying variables (disc signal, disc contour, HIZ, etc.). However, we compared the number of increased ADD variables between groups in a post hoc analysis (Figure 3 ).
Several disc prostheses with different mechanical and geometrical properties are in use. 39 Different prosthesis designs allow different ROM, and the prosthesis used in this trial is classified as semi-constrained. 39 The mobility in the treated level can affect the development of ADD, 22, 23 and the development of ADD may have been different if another prosthesis design had been used.
In conclusion, the development of ADD at 8-year followup did not differ between nonoperative treatment and TDR, and was not related to the clinical outcome. Hence, TDR, as performed in the present study, does not seem to increase the long-term risk of developing ADD, and patients developing ADD do not seem to have a worse outcome. Our results are similar with a recent study with long-term follow-up after lumbar fusion compared with nonoperative treatment, 6 suggesting that factors other than fusion or TDR are important for the development of ADD.
Key Points
No differences were observed between lumbar total disc replacement and nonoperative treatment in the development of adjacent disc degeneration at 8-year follow-up. No association was found between increased adjacent disc degeneration and the clinical outcome. Larger studies with longer follow-up are warranted.
